Aduhelm’s costs: Medicare recipients won’t get premium reduction until 2023
By
Alicia Lasek (f3)
Jun 01, 2022
A cost overestimate that bumped up Medicare premiums for seniors in 2022 will not be corrected until the following year. The spike is tied to coverage for Alzheimer’s drug Aduhelm.
Providers receive reprieve on advanced Medicare loan repayments
By
Danielle Brown
Oct 09, 2020
Providers who participated in the Medicare Accelerated and Advanced Payment Program for COVID-19 emergency will now have another year to pay back the loan thanks to Congress.
‘Not a shock:’ MedPAC considering 5% pay cut for SNFs
By
Danielle Brown
Dec 14, 2021
The Medicare Payment Advisory Commission is leaning toward recommending a 5% pay cut for skilled nursing facilities in fiscal 2021 after a new report found that Medicare margins may indicate SNF pay rates...
Eli Lilly expects Medicare about-face on Alzheimer’s drugs coverage
By
Alicia Lasek
Apr 23, 2023
New data on Lilly’s experimental drug donanemab may influence CMS’s restrictive stance on coverage of this and other amyloid-busting Alzheimer’s treatments, a company executive says.